ROSELLINI, MATTEO

ROSELLINI, MATTEO  

Borsisti  

Mostra records
Risultati 1 - 20 di 45 (tempo di esecuzione: 0.053 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience Mollica, V.; Marchetti, A.; Fraccascia, N.; Nanni, C.; Tabacchi, E.; Malizia, C.; Argalia, G.; Ro...sellini, M.; Tassinari, E.; Paccapelo, A.; Fanti, S.; Massari, F. 2024-01-01 ESMO OPEN - 1.01 Articolo in rivista -
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis Rosellini, Matteo; Mollica, Veronica; Marchetti, Andrea; Coluccelli, Sara; Giunchi, Francesca; Ta...ssinari, Elisa; Ricci, Costantino; Fiorentino, Michelangelo; Tallini, Giovanni; De Biase, Dario; Massari, Francesco 2024-01-01 PATHOLOGY, RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations Maffezzoli, Michele; Santoni, Matteo; Mazzaschi, Giulia; Rodella, Sara; Lai, Eleonora; Maruzzo, M...arco; Basso, Umberto; Bimbatti, Davide; Iacovelli, Roberto; Anghelone, Annunziato; Fiala, Ondřej; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Lolli, Cristian; Massari, Francesco; Rosellini, Matteo; Mollica, Veronica; Nasso, Cecilia; Acunzo, Alessandro; Silini, Enrico Maria; Quaini, Federico; De Filippo, Massimo; Brunelli, Matteo; Banna, Giuseppe L; Rescigno, Pasquale; Signori, Alessio; Buti, Sebastiano 2024-01-01 CLINICAL & EXPERIMENTAL METASTASIS - 1.01 Articolo in rivista Clin Exp Metastasis 2024 [Red cell Buti].pdf10585_2024_10266_MOESM1_ESM.docx
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study Massari, Francesco; Santoni, Matteo; Takeshita, Hideki; Okada, Yohei; Tapia, Jose Carlos; Basso, ...Umberto; Maruzzo, Marco; Scagliarini, Sarah; Büttner, Thomas; Fornarini, Giuseppe; Myint, Zin W; Galli, Luca; Souza, Vinicius Carrera; Pichler, Renate; De Giorgi, Ugo; Gandur, Nathalia; Lam, Elaine T; Gilbert, Danielle; Popovic, Lazar; Grande, Enrique; Mammone, Giulia; Berardi, Rossana; Crabb, Simon J; Kemp, Robert; Molina-Cerrillo, Javier; Freitas, Marcelo; Luz, Murilo; Iacovelli, Roberto; Calabrò, Fabio; Tural, Deniz; Atzori, Francesco; Küronya, Zsófia; Chiari, Rita; Campos, Saul; Caffo, Orazio; Fay, André P; Kucharz, Jakub; Zucali, Paolo Andrea; Rinck, José Augusto; Zeppellini, Annalisa; Bastos, Diogo Assed; Aurilio, Gaetano; Mota, Augusto; Trindade, Karine; Ortega, Cinzia; Sade, Juan Pablo; Rizzo, Mimma; Fiala, Ondřej; Vau, Nuno; Giannatempo, Patrizia; Barillas, Allan; Monteiro, Fernando Sabino M; Dauster, Breno; Mennitto, Alessia; Nogueira, Lucas; de Carvalho Fernandes, Roni; Seront, Emmanuel; Aceituno, Luís Garcia; Grillone, Francesco; Cutuli, Hernan Javier; Fernandez, Mauricio; Bassanelli, Maria; Kopp, Ray Manneh; Roviello, Giandomenico; Abahssain, Halima; Procopio, Giuseppe; Milella, Michele; Kopecky, Jindrich; Martignetti, Angelo; Messina, Carlo; Caitano, Manuel; Inman, Eva; Kanesvaran, Ravindran; Herchhorn, Daniel; Santini, Daniele; Bamias, Aristotelis; Bisonni, Renato; Mosca, Alessandra; Morelli, Franco; Maluf, Fernando; Soares, Andrey; Nunes, Fernando; Pinto, Alvaro; Zgura, Anca; Incorvaia, Lorena; Ansari, Jawaher; Zabalza, Ignacio Ortego; Landmesser, Johannes; Rizzo, Alessandro; Mollica, Veronica; Marchetti, Andrea; Rosellini, Matteo; Sorgentoni, Giulia; Battelli, Nicola; Buti, Sebastiano; Porta, Camillo; Bellmunt, Joaquim 2024-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista Cancer Immunology Immunotherapy 2024 [ARON2 Pembro].pdf262_2024_3682_MOESM1_ESM.docx
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning Massari, Francesco; Rosellini, Matteo; Mollica, Veronica 2024-01-01 NATURE REVIEWS. UROLOGY - 1.01 Articolo in rivista -
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro;... Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco 2024-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista ERPMDD 2024 [TGR].pdf
What is the risk of hepatotoxicity induced by immune-checkpoint inhibitors and how can we avoid it? Tassinari, Elisa; Rosellini, Matteo; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco 2024-01-01 EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY - 1.01 Articolo in rivista -
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer Nuvola, Giacomo; Santoni, Matteo; Rizzo, Mimma; Rosellini, Matteo; Mollica, Veronica; Rizzo, Ales...sandro; Marchetti, Andrea; Battelli, Nicola; Massari, Francesco 2023-01-01 EXPERT REVIEW OF ANTICANCER THERAPY - 1.01 Articolo in rivista -
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo,... Alessandro; Massari, Francesco; Mollica, Veronica 2023-01-01 EXPERT OPINION ON DRUG SAFETY - 1.01 Articolo in rivista -
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis Santoni, Matteo; Rizzo, Alessandro; Kucharz, Jakub; Mollica, Veronica; Rosellini, Matteo; Marchet...ti, Andrea; Tassinari, Elisa; Monteiro, Fernando Sabino Marques; Soares, Andrey; Molina-Cerrillo, Javier; Grande, Enrique; Battelli, Nicola; Massari, Francesco 2023-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma? Conci, Nicole; Tassinari, Elisa; Tateo, Valentina; Rosellini, Matteo; Marchetti, Andrea; Ricci, C...ostantino; Chessa, Francesco; Santoni, Matteo; Grande, Enrique; Mollica, Veronica; Massari, Francesco 2023-01-01 MOLECULAR DIAGNOSIS & THERAPY - 1.01 Articolo in rivista Molecular Diagn Ther 2023 [Neoadj UC].pdf
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study Rizzo, Alessandro; Mollica, Veronica; Tateo, Valentina; Tassinari, Elisa; Marchetti, Andrea; Rose...llini, Matteo; De Luca, Raffaele; Santoni, Matteo; Massari, Francesco 2023-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis Rizzo, Alessandro; Nuvola, Giacomo; Palmiotti, Gennaro; Ahcene-Djaballah, Selma; Mollica, Veronic...a; Rosellini, Matteo; Marchetti, Andrea; Nigro, Maria Concetta; Tassinari, Elisa; Macrini, Sveva; Massari, Francesco 2023-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Prostate cancer and novel pharmacological treatment options - what's new for 2022? Marchetti, Andrea; Tassinari, Elisa; Rosellini, Matteo; Rizzo, Alessandro; Massari, Francesco; Mo...llica, Veronica 2023-01-01 EXPERT REVIEW OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -
Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco 2023-01-01 EUROPEAN UROLOGY - 1.01 Articolo in rivista -
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca...; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco 2023-01-01 PATHOLOGY RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study Mollica, Veronica; Rizzo, Alessandro; Marchetti, Andrea; Tateo, Valentina; Tassinari, Elisa; Rose...llini, Matteo; Massafra, Raffaella; Santoni, Matteo; Massari, Francesco 2023-01-01 CLINICAL AND EXPERIMENTAL MEDICINE - 1.01 Articolo in rivista Clin Exp Med. 2023 [MOUSEION 06].pdf
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy Marchese, Paola Valeria; Mollica, Veronica; De Biase, Dario; Giunchi, Francesca; Tassinari, Elisa...; Marchetti, Andrea; Rosellini, Matteo; Nuvola, Giacomo; Maloberti, Thais; Fiorentino, Michelangelo; Massari, Francesco 2022-01-01 PATHOLOGY RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study Rizzo A.; Mollica V.; Marchetti A.; Nuvola G.; Rosellini M.; Tassinari E.; Molina-Cerrillo J.; My...int Z.W.; Buchler T.; Monteiro F.S.M.; Grande E.; Santoni M.; Massari F. 2022-01-01 CANCERS - 1.01 Articolo in rivista Cancers 2022 [MOUSEION04].pdfcancers-14-04142-s001.zip
Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw Mollica V.; Nuvola G.; Tassinari E.; Nigro M.C.; Marchetti A.; Rosellini M.; Rizzo A.; Errani C.;... Massari F. 2022-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista Current Oncology 2022 [Bone agents PCa].pdf